Mahesh Krishnan MD MPH is currently the Group Vice President for R and D for DaVita.

Dr. Krishnan is well experienced in healthcare. He is currently co leads the DaVita Venture Group, Davita's external innovation arm. Previously, he served DaVita's founding International CMO, and oversees Public Policy in DC. Prior to DaVita he was the Executive Director of Medical Policy, Nephrology Therapeutic Area Head for Global Health Economics, and Global Development Leader for Epogen(R) at AMGEN Inc. During his tenure with AMGEN, he played an important role in the 2007 FDA Cardio Renal Drug Advisory Panel for Erythropoietic Stimulating Agents, served as the primary contact for the Dialysis Outcomes Practice Patterns Study, and led many important research projects focused on observational research and dialysis care. He was the founder and managing partner of the Clinical Consulting and Research Center in Fairfax, VA, and prior to that, was in practice in Northern Virginia for nearly five years.